Lipocine
LPCN
LPCN
58 hedge funds and large institutions have $30.3M invested in Lipocine in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less capital invested
Capital invested by funds: $36.5M → $30.3M (-$6.18M)
Holders
58
Holding in Top 10
1
Calls
$160K
Puts
–
Top Buyers
| 1 | +$697K | |
| 2 | +$684K | |
| 3 | +$270K | |
| 4 |
Morgan Stanley
New York
|
+$192K |
| 5 |
RA
Royce & Associates
New York
|
+$179K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$863K | |
| 3 | -$651K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$112K |
| 5 |
EEG
E.E. Geduld
|
-$55.9K |